Clinical Trial: A Pharmacokinetic Study of Cefepime After Administration Into Dialysate in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Research Study on the Pharmacokinetic Profile of Intraperitoneal Cefepime in Patients With Continuous Ambulatory Peritoneal Dialysis (CAPD) Peritonitis

Brief Summary: Cefepime is a broad-spectrum antibiotic used in treating CAPD peritonitis. However, medical knowledge has been lacking with regard to its pharmacokinetic profile after it has been administered intraperitoneally. The current study aims at determining the drug level at different time after the drug has been added into the peritoneal fluid in patients with CAPD peritonitis. The results of this study will finally leads to rational prescription of this drug at correct dosages.

Detailed Summary:
Sponsor: Hospital Authority, Hong Kong

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Hospital Authority, Hong Kong

Dates:
Date Received: July 6, 2007
Date Started: November 2005
Date Completion:
Last Updated: June 14, 2011
Last Verified: June 2011